Advertisement
Screener

BIOTRICITY INC. (BTCY) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised

2.8 / 5 stars · 68/120 Roast Me

BIOTRICITY INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised

BIOTRICITY INC. (BTCY) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2026-08-19

  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2026-06-30 was 0.00 shares.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2022-12-31 was 306.60K shares, a 42.86% decline year-over-year.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2022-06-30 was 11.79K shares, a 91.45% decline year-over-year.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2021-12-31 was 536.57K shares.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2023 was 53.07K shares, a 96.37% decline from fiscal 2022.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2022 was 1.46M shares, a 1397.35% increase from fiscal 2021.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2021 was 97.50K shares.
  • BIOTRICITY INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2019 was 62.84K shares, a 82.67% decline from fiscal 2018.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 14 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 15 month
2026-06-300.00 shares
10-Q · filed 2026-08-19
2023-03-3153.07K shares
10-K · filed 2024-06-27
318.40K shares
10-K · filed 2023-06-29
2022-12-31306.60K shares
10-Q · filed 2023-02-14
2022-06-3011.79K shares
10-Q · filed 2023-02-14
2022-03-311.46M shares
10-K · filed 2023-06-29
2021-12-31536.57K shares
10-Q · filed 2022-02-14
883.23K shares
derived: sum of 2 quarters · filed 2022-02-14
1.02M shares
derived: sum of 3 quarters · filed 2022-02-14
2021-09-30346.66K shares
10-Q · filed 2022-02-14
484.63K shares
derived: sum of 2 quarters · filed 2022-02-14
2021-06-30137.97K shares
10-Q · filed 2022-02-14
2021-03-3197.50K shares
10-K · filed 2022-07-14
2020-09-3097.50K shares
10-Q · filed 2021-02-16
1.08M shares
derived: sum of 2 quarters · filed 2021-02-16
2020-06-30986.51K shares
10-Q · filed 2020-08-14
2019-06-30458.20K shares
10-Q · filed 2021-02-16
2019-03-3162.84K shares
10-K · filed 2020-07-15
2018-06-3062.84K shares
10-Q · filed 2020-11-13
2018-03-31362.69K shares
10-K · filed 2020-07-15
2017-03-31131.37K shares
10-K · filed 2019-07-16
131.37K shares
10-K · filed 2020-07-15